Income Statement (TTM)
Innate Pharma S.A. Income Statement shows changes in income and expenses over a period of time. Income Statement data includes Sales and Revenue, Gross Profit, Research and Development (R&D), Selling, General and Administrative Expense (SG&A), Operating Income, Income Tax Expense, Interest Expense, Non-Operating Income, Earnings per Share (EPS), and Shares Outstanding.
All numbers are times 1,000,000 except per share units.
|
2020 09-30 |
2020 12-31 |
2021 03-31 |
2021 06-30 |
2021 12-31 |
2022 03-31 |
2022 06-30 |
2022 09-30 |
2022 12-31 |
2023 03-31 |
2023 06-30 |
2023 09-30 |
2023 12-31 |
2024 03-31 |
2024 06-30 |
2024 09-30 |
2024 12-31 |
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 67 | 70 | 58 | 46 | 25 | 41 | 57 | 57 | 58 | 55 | 52 | 57 | 62 | 48 | 34 | 27 | 20 |
| Change (%) | 4.25 | -16.79 | -20.18 | -46.69 | 65.33 | 39.51 | 0.61 | 0.61 | -4.67 | -4.90 | 8.95 | 8.21 | -22.59 | -29.19 | -20.22 | -25.35 | |
| % of Revenue | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 |
| Cost Of Sales | 66 | 50 | 45 | 39 | 47 | 49 | 51 | 51 | 52 | 55 | 58 | 57 | 56 | 55 | 54 | 53 | 52 |
| Change (%) | -24.90 | -10.35 | -11.55 | 19.25 | 3.99 | 3.83 | 0.90 | 0.89 | 6.29 | 5.92 | -1.84 | -1.87 | -2.12 | -2.17 | -1.55 | -1.58 | |
| % of Revenue | 98.89 | 71.24 | 76.76 | 85.06 | 190.28 | 119.68 | 89.07 | 89.33 | 89.58 | 99.88 | 111.24 | 100.23 | 90.88 | 114.92 | 158.77 | 195.93 | 258.34 |
| Gross Operating Profit | 1 | 20 | 13 | 7 | -22 | -8 | 6 | 6 | 6 | 0 | -6 | -0 | 6 | -7 | -20 | -26 | -32 |
| Change (%) | 2,606.00 | -32.75 | -48.70 | -422.13 | -63.96 | -177.50 | -1.74 | -1.77 | -98.89 | -8,871.64 | -97.81 | -4,455.81 | -226.70 | 178.93 | 30.22 | 23.21 | |
| % of Revenue | 1.11 | 28.76 | 23.24 | 14.94 | -90.28 | -19.68 | 10.93 | 10.67 | 10.42 | 0.12 | -11.24 | -0.23 | 9.12 | -14.92 | -58.77 | -95.93 | -158.34 |
| SG&A | 31 | 19 | 18 | 17 | 26 | 25 | 25 | 24 | 22 | 21 | 19 | 19 | 18 | 19 | 19 | 19 | 20 |
| Change (%) | -38.99 | -4.86 | -5.11 | 48.92 | -0.99 | -1.00 | -5.17 | -5.45 | -6.68 | -7.15 | -2.96 | -3.05 | 1.20 | 1.18 | 2.64 | 2.58 | |
| % of Revenue | 46.50 | 27.21 | 31.11 | 36.99 | 103.32 | 61.88 | 43.91 | 41.39 | 38.90 | 38.08 | 37.18 | 33.12 | 29.67 | 38.79 | 55.42 | 71.31 | 97.99 |
| R&D | |||||||||||||||||
| Change (%) | |||||||||||||||||
| % of Revenue | |||||||||||||||||
| OpEx | 99 | 69 | 63 | 57 | 73 | 74 | 76 | 75 | 74 | 76 | 78 | 76 | 74 | 73 | 72 | 72 | 72 |
| Change (%) | -30.35 | -8.18 | -8.91 | 26.24 | 2.24 | 2.19 | -1.10 | -1.12 | 2.36 | 2.31 | -2.12 | -2.17 | -1.30 | -1.32 | -0.47 | -0.47 | |
| % of Revenue | 147.37 | 98.45 | 108.64 | 123.98 | 293.60 | 181.56 | 132.98 | 130.72 | 128.48 | 137.96 | 148.42 | 133.34 | 120.55 | 153.71 | 214.19 | 267.24 | 356.32 |
| Operating Income | -32 | 1 | -5 | -11 | -48 | -33 | -19 | -18 | -16 | -21 | -25 | -19 | -13 | -26 | -39 | -45 | -52 |
| Change (%) | -103.40 | -564.92 | 121.51 | 330.39 | -30.35 | -43.58 | -6.30 | -6.72 | 27.07 | 21.30 | -24.98 | -33.30 | 102.27 | 50.56 | 16.84 | 14.41 | |
| % of Revenue | -47.37 | 1.55 | -8.64 | -23.98 | -193.60 | -81.56 | -32.98 | -30.72 | -28.48 | -37.96 | -48.42 | -33.34 | -20.55 | -53.71 | -114.19 | -167.24 | -256.32 |
| Interest Expense | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -1 | -1 | -1 | -1 | -1 | -1 |
| Change (%) | 1.34 | -1.91 | -1.94 | -4.88 | 5.45 | 5.17 | -8.38 | -9.15 | 22.57 | 18.41 | 26.56 | 20.98 | -1.88 | -1.91 | -4.06 | -4.23 | |
| % of Revenue | -0.50 | -0.49 | -0.58 | -0.71 | -1.26 | -0.81 | -0.61 | -0.55 | -0.50 | -0.64 | -0.80 | -0.93 | -1.04 | -1.32 | -1.82 | -2.19 | -2.81 |
| Net Income | -54 | -64 | -71 | -77 | -53 | -38 | -23 | -40 | -58 | -60 | -63 | -35 | -8 | -21 | -34 | -42 | -49 |
| Change (%) | 18.14 | 10.46 | 9.47 | -31.74 | -28.43 | -39.71 | 77.49 | 43.66 | 3.95 | 3.80 | -43.96 | -78.45 | 174.91 | 63.63 | 22.64 | 18.46 | |
| % of Revenue | -80.92 | -91.70 | -121.74 | -166.96 | -213.78 | -92.55 | -39.99 | -70.55 | -100.74 | -109.85 | -119.90 | -61.67 | -12.28 | -43.62 | -100.78 | -154.93 | -245.87 |
Source: Capital IQ
